The GSK, Amgen and Novo-backed cancer drug developer went public in an upsized offering priced above its range.
Author: Jordan Williams
John Lewis acquires Opun
Aviva Ventures has exited home improvement services marketplace Opun in a $4.7m purchase by John Lewis Partnership.